Groundbreaking Study Validates FloraWorks Ultra-Pure Cannabinol-Based Sleep Aid, TruCBN™
Cannabinol (CBN), a non-psychoactive compound derived from cannabis, is gaining attention for its therapeutic potential. In this study, participants reported significant improvements in sleep onset, duration, and quality, positioning TruCBN™ as a natural alternative to mainstream sleep aids.
September 4 2024 Webinar: FDA & The Collapse of Lykos | The Opportunity for Psychedelics
In this Bonaventure Equity live stream webinar, hosted by Ross O’Brien, founder and managing partner, the focus is on the recent FDA decision regarding Lycos’ MDMA application, intended for treating PTSD. Ross is joined by experts Mike McCormick, a PhD chemist, and Michael Werner, a partner at the law firm Holland and Knight.